| Nancy Shahata, | |
|
732 Valley Rd, Montclair, NJ 07043-1521 | |
| (973) 744-2113 | |
| Not Available |
| Full Name | Nancy Shahata |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 732 Valley Rd, Montclair, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851979561 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI03869500 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Shahata, 732 Valley Rd, Montclair, NJ 07043-1521 Ph: () - | Nancy Shahata, 732 Valley Rd, Montclair, NJ 07043-1521 Ph: (973) 744-2113 |
News Archive
Those who smoke and drink heavily may develop pancreatic cancer at an earlier age than those who don't, according to a study led by a University of Michigan Health System gastroenterologist.
Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.
Osteoarthritis (OA) and degenerative disc disease (DDD) are common, chronic musculoskeletal disorders. Both diseases cause joint pain, loss of function, and decreased quality of life for the more than 27 million OA and 59 million DDD suffers in the US. According to a 2003 Medical Expenditure Panel Survey, arthritis such as OA costs the U.S. economy nearly $128 billion per year in medical care and indirect expenses including lost wages and productivity.
Anadis Ltd, a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel.
New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2
› Verified 4 days ago
Mr. James Anthony Vasquez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 19 Mendl Ter, Montclair, NJ 07042 Phone: 973-809-3456 | |
Mona Hanna Nashed, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6123 | |
Ibrahim Salib, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 Claremont Ave, Montclair, NJ 07042 Phone: 973-783-1741 | |
Dr. Jonathan Gonzalez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 Grove St, Montclair, NJ 07042 Phone: 973-744-5550 | |
Laila Saleh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 415 Bloomfield Ave, Montclair, NJ 07042 Phone: 973-746-6500 | |
Mr. Mohamed Adel Dandash, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Church St, Montclair, NJ 07042 Phone: 347-608-1675 Fax: 973-707-2692 | |
Stuart Ross Keil, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 732 Valley Rd, Montclair, NJ 07043 Phone: 973-733-2113 Fax: 973-744-2691 |